Adenomyosis and Endometriosis-Related Infertility

A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Obstetrics and Gynecology".

Deadline for manuscript submissions: closed (20 November 2025) | Viewed by 783

Special Issue Editors


E-Mail Website
Guest Editor
IRCCS, Ospedale Policlinico San Martino, University of Genova, Genova, Italy
Interests: gynecology; endometriosis; fibroids; laparoscopy; hormonal therapy; hysteroscopy; ultrasonography; gynecological surgery; minimally invasive surgery; infertility
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Adenomyosis and endometriosis are significant contributors to infertility, posing considerable challenges in reproductive medicine. Adenomyosis affects fertility through multiple mechanisms, including disruption of the normal uterine architecture, impaired uterine contractility, altered local inflammatory responses, and disturbances in endometrial receptivity. These changes may impede embryo implantation and increase the risk of miscarriage. Endometriosis contributes to infertility via several pathways. The presence of ectopic endometrial tissue induces chronic inflammation, adhesions, and the anatomical distortion of pelvic structures, negatively impacting gamete transport and ovarian function. Moreover, endometriosis may diminish the ovarian reserve, negatively influence oocyte quality, and compromise embryo implantation due to altered endometrial receptivity mediated by pro-inflammatory cytokines and growth factors.

This Special Issue aims to provide an overview on endometriosis and adenomyosis-related infertility.

Treatment strategies for infertility associated with adenomyosis and endometriosis include medical management to reduce inflammation and surgical intervention to restore pelvic anatomy. Assisted reproductive technologies (ARTs), such as in vitro fertilization (IVF), are often recommended when conservative approaches fail or when anatomical distortions significantly impact reproductive potential. Evidence suggests that a multidisciplinary approach integrating surgical, medical, and ART modalities provides the most effective management to optimize fertility outcomes in patients with adenomyosis and endometriosis.

All types of manuscripts are welcome, including original research articles and reviews (narrative and systematic with/without meta-analysis).

Prof. Dr. Simone Ferrero
Dr. Giuseppe Gullo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • endometriosis
  • adenomyosis
  • infertility
  • in vitro fertilization
  • surgery
  • laparoscopy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 577 KB  
Article
The Significance of Serum CA-125 Level on the Live Birth Rates of In Vitro Fertilisation in Women with Endometriosis
by Hoi Ki Chung, Shui Fan Lai, Rebecca Siu Fan Wan, Jennifer Ka Yee Ko, Ernest Hung Yu Ng and Raymond Hang Wun Li
Medicina 2026, 62(1), 53; https://doi.org/10.3390/medicina62010053 - 26 Dec 2025
Viewed by 367
Abstract
Background and Objectives: To evaluate the significance of serum CA-125 level on the live birth rate of in vitro fertilization (IVF) in women with endometriosis. Materials and Methods: This retrospective observational study included women with endometriosis who underwent one stimulated IVF [...] Read more.
Background and Objectives: To evaluate the significance of serum CA-125 level on the live birth rate of in vitro fertilization (IVF) in women with endometriosis. Materials and Methods: This retrospective observational study included women with endometriosis who underwent one stimulated IVF cycle. Serum CA-125 levels were measured in archived serum samples collected prior to ovarian stimulation, on the day of ovulation trigger, and during frozen embryo transfer. Serum CA-125 levels were compared between cycles with and without a live birth in both stimulated IVF and frozen embryo transfer cycles, with a subgroup analysis using a cut-off of 35 IU/L. Results: Within the same patient undergoing the same IVF cycle, serum CA-125 level on the trigger day of the stimulated cycle was significantly lower than the baseline level before stimulation started (35.1 IU/L [21.0–64.5 IU/L] vs. 46.8 IU/L [25.9–104.0 IU/L], p < 0.001), but was higher than that in the frozen embryo transfer cycles (31.7 IU/L [19.9–58.7 IU/L] vs. 27.3 IU/L [18.1–59.9 IU/L], p = 0.041). Serum CA-125 levels were not associated with the live birth rate in the stimulated IVF cycle and frozen embryo transfer cycles. In subgroup analysis, women with serum CA-125 level ≥ 35 IU/L on the trigger day had a significantly higher pregnancy rate from the fresh embryo transfer cycle than those with level < 35 IU/L (adjusted odds ratio 4.126, 95% CI 1.241–13.720, p = 0.021). The cut-off of 35 IU/L did not show significant differences in live birth rate for either stimulated or frozen embryo transfer cycles. Conclusions: In women with endometriosis, no significant differences in serum CA-125 levels were found between those with and without a live birth in fresh and frozen embryo transfer cycles. In fresh embryo transfer cycles, those with serum CA-125 ≥ 35 IU/L had significantly higher pregnancy rates. Full article
(This article belongs to the Special Issue Adenomyosis and Endometriosis-Related Infertility)
Show Figures

Figure 1

Back to TopTop